We are live on
!
Find out more
O
OppenheimerFunds Portfolio holdings
AUM
$80.4B
1-Year Est. Return
15.1%
This Fund
S&P 500
This Quarter
Est. Return
+2%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.05%
5 Year Est. Return
+91.1%
10 Year Est. Return
–
AUM
$89.6B
AUM Growth
-$307M
(-0.34%)
Cap. Flow
-$521M
Cap. Flow
% of AUM
-0.58%
Top 10 Holdings %
Top 10 Hldgs %
13.13%
Holding
1,015
New
93
Increased
423
Reduced
329
Closed
118
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$536M |
| 2 |
WPZ
Williams Partners L.P.
WPZ
|
+$409M |
| 3 |
PepsiCo
PEP
|
+$325M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$220M |
| 5 |
PG&E
PCG
|
+$218M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Petrobras Class A
PBR.A
|
+$417M |
| 2 |
WPZ
WILLIAMS PARTNERS L.P. COM UTS REPTG L.P. INT
WPZ
|
+$383M |
| 3 |
AGN
Allergan Inc
AGN
|
+$340M |
| 4 |
AbbVie
ABBV
|
+$257M |
| 5 |
Exelon
EXC
|
+$250M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 17.02% |
| 2 | Financials | 13.78% |
| 3 | Healthcare | 12.41% |
| 4 | Communication Services | 11.87% |
| 5 | Consumer Discretionary | 10.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PETX
776
DELISTED
Aratana Therapeutics, Inc.
PETX
| $8.59M | 0.01% |
536,612
+5,960
| +1% | +$106K |
|
777
Inogen
INGN
$167M
| $8.56M | 0.01% |
+267,490
| New | +$8.63M |
|
778
Avista
AVA
$3.47B
| $8.54M | 0.01% |
249,740
+32,610
| +15% | +$1.14M |
|
779
Textron
TXT
$16.6B
| $8.46M | 0.01% |
190,820
-210,680
| -52% | -$9.16M |
|
|
DPLO
780
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $8.37M | 0.01% |
+242,060
| New | +$6.59M |
|
781
Avnet
AVT
$7.33B
| $8.29M | 0.01% |
+186,330
| New | +$8.23M |
|
782
Sibanye-Stillwater
SBSW
$5.92B
| $8.27M | 0.01% |
+1,028,976
| New | +$9.47M |
|
783
Teradata
TDC
$2.68B
| $8.26M | 0.01% |
187,210
+131,510
| +236% | +$5.75M |
|
784
Apollo Global Management
APO
$70.7B
| $8.19M | 0.01% |
379,138
+24,110
| +7% | +$562K |
|
785
Marcus & Millichap
MMI
$1.15B
| $8.13M | 0.01% |
+216,780
| New | +$7.74M |
|
|
B
786
Barrick Mining
B
$62.2B
| $8.11M | 0.01% |
740,000
+481,100
| +186% | +$5.69M |
|
787
Matador Resources
MTDR
$6.31B
| $7.87M | 0.01% |
359,210
-13,410
| -4% | -$289K |
|
|
RKT
788
DELISTED
ROCK-TENN COMPANY CL-A
RKT
| $7.79M | 0.01% |
120,740
-38,730
| -24% | -$2.54M |
|
|
CYBR
789
DELISTED
CyberArk
CYBR
| $7.7M | 0.01% |
+138,530
| New | +$6.54M |
|
|
LF
790
DELISTED
LEAPFROG ENTERPRISES INC.
LF
| $7.63M | 0.01% |
3,500,000
| – | – |
|
|
RNET
791
DELISTED
RigNet, Inc.
RNET
| $7.51M | 0.01% |
262,699
+7,413
| +3% | +$244K |
|
|
ATML
792
DELISTED
ATMEL CORP
ATML
| $7.46M | 0.01% |
+906,810
| New | +$7.61M |
|
|
NUVA
793
DELISTED
NuVasive, Inc.
NUVA
| $7.29M | 0.01% |
+158,410
| New | +$7.36M |
|
|
MSCC
794
DELISTED
Microsemi Corp
MSCC
| $7.27M | 0.01% |
+205,490
| New | +$6.36M |
|
795
Neurocrine Biosciences
NBIX
$17.7B
| $7.27M | 0.01% |
+183,100
| New | +$6.55M |
|
796
Everest Group
EG
$15.2B
| $7.27M | 0.01% |
41,780
+11,230
| +37% | +$1.97M |
|
|
PDCE
797
DELISTED
PDC Energy, Inc.
PDCE
| $7.18M | 0.01% |
+132,790
| New | +$6.43M |
|
798
Idexx Laboratories
IDXX
$42.9B
| $7.16M | 0.01% |
+92,700
| New | +$7.21M |
|
799
Moody's
MCO
$81.7B
| $7.15M | 0.01% |
68,851
-52,230
| -43% | -$5.05M |
|
800
Columbia Sportswear
COLM
$3.19B
| $7.07M | 0.01% |
+116,120
| New | +$5.88M |
|
Similar funds
TA
TCIM
HFS
SBAM
BB
SA
WF
BCPEM
OppenheimerFunds's Q1 2015 Portfolio in Review
As of Q1 2015, OppenheimerFunds held 1,015 positions worth $89.6B, down 0.34% from $89.9B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
OppenheimerFunds's Q1 2015 filing shows 93 new, 423 increased, 329 reduced and 118 closed positions. Its largest new stake was UBS Group: 30,806,912 shares worth $578M. The largest sale was Petrobras Class A, an estimated $417M.
By sector, the portfolio is most concentrated in Energy at 17% of assets, down from 19% a quarter earlier, followed by Financials and Healthcare.
- OppenheimerFunds's largest Q1 2015 buy was UBS Group: 30,806,912 shares worth $578M.
- OppenheimerFunds added most to Williams Partners L.P. in Q1 2015, an estimated $409M increase.
- OppenheimerFunds's biggest Q1 2015 reduction was AbbVie, cutting an estimated $257M.
- OppenheimerFunds fully exited Petrobras Class A in Q1 2015, selling an estimated $417M.
- OppenheimerFunds's ten largest holdings make up 13% of its $89.6B portfolio in Q1 2015.
- OppenheimerFunds opened 93 new positions and closed 118 in Q1 2015.
- OppenheimerFunds's portfolio value fell 0.34% quarter-over-quarter to $89.6B.
Based on OppenheimerFunds's 13F filing for Q1 2015, filed 15 May 2015.